Encapsulated mesenchymal stromal cells for in vivo transplantation

Biotechnology and Bioengineering

Volumn 108, Issue 11, 2011, Pages 2747-2758

  Barminko, Jeffrey ^a   Kim, Jae Hwan ^b   Otsuka, Seiji ^b   Gray, Andrea ^a   Schloss, Rene ^a   Grumet, Martin ^b   Yarmush, Martin L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Encpasulation; Macrophage; Mesenchymal stem cells; Mesenchymal stromal cells; Spinal cord injury; Transplantation

Indexed keywords

ANIMAL MODEL; ANTI-INFLAMMATORIES; CAUDA EQUINA; CYTOKINES; EFFECTIVE TRANSLATION; ENCPASULATION; IN-VITRO; IN-VIVO; INFLAMMATORY RESPONSE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMAL CELLS; RAT SPINAL CORD; SPINAL CORD INJURY; SPINAL CORDS; THERAPEUTIC PROTOCOLS;

CELL CULTURE; DOSIMETRY; PATIENT REHABILITATION; STEM CELLS; TISSUE; TRANSPLANTATION (SURGICAL);

MACROPHAGES;

ALGINIC ACID; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ENCAPSULATION; CELL TRANSPLANTATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMOBILIZED CELL; IMMUNOMODULATION; LUMBAR PUNCTURE; MACROPHAGE; MESENCHYME CELL; MICROENCAPSULATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; STROMA CELL;

ALGINATES; ANIMALS; CELL SURVIVAL; CELLS, IMMOBILIZED; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCURONIC ACID; HEXURONIC ACIDS; HISTOCYTOCHEMISTRY; HUMANS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICROSPHERES; NITRIC OXIDE SYNTHASE TYPE II; RATS; SPINAL CORD INJURIES; TRANSPLANTATION;

ANIMALIA; RATTUS;

EID: 80053053711     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23233     Document Type: Article

References (57)

1. Bakshi A, Hunter C, Swanger S, Lepore A, Fischer I. 2004. Minimally invasive delivery of stem cells for spinal cord injury: Advantages of the lumbar puncture technique. J Neurosurg Spine 1(3): 330-337.
2. Bakshi A, Barshinger AL, Swanger SA, Madhavani V, Shumsky JS, Neuhuber B, Fischer I. 2006. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: A novel method for minimally invasive cell transplantation. J Neurotrauma 23(1): 55-65.
3. Barker RA, Widner H. 2004. Immune problems in central nervous system cell therapy. NeuroRx 1(4): 472-481.
4. Bartosh TJ, Ylostalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ. 2010. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci USA 107(31): 13724-13729.
5. Basso DM, Beattie MS, Bresnahan JC. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139(2): 244-256.
6. Caplan AI, Dennis JE. 2006. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5): 1076-1084.
7. Cohen J, Zaleski KL, Nourissat G, Julien TP, Randolph MA, Yaremchuk MJ. 2010. Survival of porcine mesenchymal stem cells over the alginate recovered cellular method. J Biomed Mater Res A 96(1): 93-99.
8. Coyne TM, Marcus AJ, Woodbury D, Black IB. 2006. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 24(11): 2483-2492.
9. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. 2008. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294(3): C675-C682.
10. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. 1999. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14(5): 700-709.
11. Donnelly DJ, Popovich PG. 2008. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209(2): 378-388.
12. Friedenstein AJ, Latzinik NV, Gorskaya Yu F, Luria EA, Moskvina IL. 1992. Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 18(3): 199-213.
13. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, et al. 2005. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11(4): 367-368.
14. Goren A, Dahan N, Goren E, Baruch L, Machluf M. 2010. Encapsulated human mesenchymal stem cells: A unique hypoimmunogenic platform for long-term cellular therapy. FASEB J 24(1): 22-31.
15. Hardjo M, Miyazaki M, Sakaguchi M, Masaka T, Ibrahim S, Kataoka K, Huh NH. 2009. Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplant 18(1): 89-99.
16. Hasegawa K, Chang Y-W, Li H, Berlin Y, Ikeda O, Kane-Goldsmith N, Grumet M. 2005. Embryonic radial glia bridge spinal cord lesions and promote functional recovery following spinal cord injury. Exp Neurol 193: 394-410.
17. Heile AM, Wallrapp C, Klinge PM, Samii A, Kassem M, Silverberg G, Brinker T. 2009. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett 463(3): 176-181.
18. Jones TB, McDaniel EE, Popovich PG. 2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11(10): 1223-1236.
19. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29(43): 13435-13444.
20. Kim J, Hematti P. 2009. Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages. Exp Hematol 37(12): 1445-1453.
21. Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH. 2009. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 57(1): 13-23.
22. Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, Floege J. 2006. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17(8): 2202-2212.
23. Le Blanc K, Ringden O. 2007. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262(5): 509-525.
24. Lepore AC, Bakshi A, Swanger SA, Rao MS, Fischer I. 2005. Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord. Brain Res 1045(1-2): 206-216.
25. Li L, Sharma N, Chippada U, Jiang X, Schloss R, Yarmush ML, Langrana NA. 2008. Functional modulation of ES-derived hepatocyte lineage cells via substrate compliance alteration. Ann Biomed Eng 36(5): 865-876.
26. Li L, Davidovich AE, Schloss JM, Chippada U, Schloss RR, Langrana NA, Yarmush ML. Neural lineage differentiation of embryonic stem cells within alginate microbeads. Biomaterials 32(20): 4489-4497.
27. Li Z-H, Liao W, Cui XL, Zhao Q, Liu M, Chen YH, Liu TS, Liu NL, Wang F, Yi Y, Shao N-S. 2011. Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head. Int J Med Sci 8(1): 74-83.
28. Lu P, Tuszynski MH. 2005. Can bone marrow-derived stem cells differentiate into functional neurons? Exp Neurol 193(2): 273-278.
29. Maguire T, Novik E, Schloss R, Yarmush M. 2006. Alginate-PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng 93(3): 581-591.
30. Maguire T, Davidovich AE, Wallenstein EJ, Novik E, Sharma N, Pedersen H, Androulakis IP, Schloss R, Yarmush M. 2007. Control of hepatic differentiation via cellular aggregation in an alginate microenvironment. Biotechnol Bioeng 98(3): 631-644.
31. Murua A, Portero A, Orive G, Hernandez RM, de Castro M, Pedraz JL. 2008. Cell microencapsulation technology: Towards clinical application. J Control Release 132(2): 76-83.
32. NIH. 2011. Mesenchymal stem cell clinical studies- US National Institue of Health.
33. Nunamaker EA, Purcell EK, Kipke DR. 2007. In vivo stability and biocompatibility of implanted calcium alginate disks. J Biomed Mater Res A 83(4): 1128-1137.
34. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. 2008. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA 105(38): 14638-14643.
35. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. 2003. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100(14): 8407-8411.
36. Otsuka S, Adamson C, Sankar V, Gibbs KM, Kane-Goldsmith N, Ayer JJ, Babiarz J, Kalinski H, Ashush H, Alpert E, Lahav R, Feinstein E, Grumet M. 2011. Delayed intrathecal delivery of RhoA siRNA to the contused spinal cord inhibits allodynia, preserves white matter and increases serotonergic fiber growth. J Neurotrauma.
37. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML. 2007. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2(9): e941.
38. Parekkadan B, Tilles AW, Yarmush ML. 2008. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26(7): 1913-1919.
39. Parekkadan B, Upadhyay R, Dunham J, Iwamoto Y, Mizoguchi E, Mizoguchi A, Weissleder R, Yarmush ML. 2011. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b(+) splenocytes. Gastroenterology 140(3): 966-975 e4.
40. Parr AM, Tator CH, Keating A. 2007. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 40(7): 609-619.
41. Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ. 1995. Activation of human THP-1cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun 63(4): 1183-1187.
42. Phinney DG, Prockop DJ. 2007. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25(11): 2896-2902.
43. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147.
44. Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, Genrich K, Mehrotra S, Setty S, Smith B, Bartholomew A. 2008. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38(6): 1745-1755.
45. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G. 2005. Macrophage activation switching: An asset for the resolution of inflammation. Clin Exp Immunol 142(3): 481-489.
46. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y. 2008. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2(2): 141-150.
47. Ricardo SD, van Goor H, Eddy AA. 2008. Macrophage diversity in renal injury and repair. J Clin Invest 118(11): 3522-3530.
48. Trouche E, Girod Fullana S, Mias C, Ceccaldi C, Tortosa F, Seguelas MH, Calise D, Parini A, Cussac D, Sallerin B. 2010. Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ. Cell Transplant 19(12): 1623-1633.
49. Tsai MC, Wei CP, Lee DY, Tseng YT, Tsai MD, Shih YL, Lee YH, Chang SF, Leu SJ. 2008. Inflammatory mediators of cerebrospinal fluid from patients with spinal cord injury. Surg Neurol 70(Suppl 1S1): 19-24 discussion S1:24.
50. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. 2008. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47(5): 1634-1643.
51. Xu J, Wang W, Ludeman M, Cheng K, Hayami T, Lotz JC, Kapila S. 2008. Chondrogenic differentiation of human mesenchymal stem cells in three-dimensional alginate gels. Tissue Eng Part A 14(5): 667-680.
52. Yagi H, Soto-Gutierrez A, Kitagawa Y, Tilles AW, Tompkins RG, Yarmush ML. 2010a. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 19(6): 823-830.
53. Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B, Yarmush ML. 2010b. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18(10): 1857-1864.
54. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, Yarmush ML. 2010c. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19(6): 667-679.
55. Yang IH, Kim SH, Kim YH, Sun HJ, Kim SJ, Lee JW. 2004. Comparison of phenotypic characterization between "alginate bead" and "pellet" culture systems as chondrogenic differentiation models for human mesenchymal stem cells. Yonsei Med J 45(5): 891-900.
56. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. 2007. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21(12): 3197-3207.
57. Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, Nguyen AL, Kwon B, Le AD. 2010. Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing. Stem Cells 28(10): 1856-1868.